These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22454897)

  • 1. The assessment of potential drug interactions with a new tricyclic antidepressant drug.
    Briant RH; George CF
    Br J Clin Pharmacol; 1974 Apr; 1(2):113-8. PubMed ID: 22454897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary antipyrine kinetics in hepatic and renal disease and in patients on anticonvulsant therapy.
    Harman AW; Penhall RK; Priestly BG; Frewin DB; Phillips PJ; Clarkson AR
    Aust N Z J Med; 1977 Aug; 7(4):385-90. PubMed ID: 270989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of nisoxetine (Lilly compound 94939), a potential antidepressant, on biogenic amine uptake in man.
    Lemberger L; Terman S; Rowe H; Billings R
    Br J Clin Pharmacol; 1976 Apr; 3(2):215-20. PubMed ID: 788744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between sympathomimetic amines and antidepressant agents in man.
    Boakes AJ; Laurence DR; Teoh PC; Barar FS; Benedikter LT; Prichard BN
    Br Med J; 1973 Feb; 1(5849):311-5. PubMed ID: 4685619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of amezinium, a novel antihypotensive drug. III. Studies on the mechanism of action.
    Lenke D; Gries J; Kretzschmar R
    Arzneimittelforschung; 1981; 31(9a):1558-65. PubMed ID: 7197970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of moclobemide and tricyclic antidepressants with the tyramine pressor effect in rats.
    Burkard W; d'Agostini F; Kettler R; Da Prada M
    Psychopharmacology (Berl); 1992; 106 Suppl():S35-6. PubMed ID: 1546137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The comparative influence of pyrazidol, inkazan and other antidepressant monoamine oxidase inhibitors on the pressor effect of tyramine].
    Andreeva NI; Golovina SM; Faermark MF; Shvarts GIa; Mashkovskiĭ MD
    Farmakol Toksikol; 1991; 54(2):38-40. PubMed ID: 1884793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
    Vuitton D; Miguet JP; Camelot G; Delafin C; Joanne C; Bechtel P; Gillet M; Carayon P
    Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular responses to mianserin hydrochloride: a comparison with tricyclic antidepressant drugs.
    Burgess CD; Turner P; Wadsworth J
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):21S-28S. PubMed ID: 341940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of tyramine responses by bretylium, BW392C60, bethanidine and monoamine oxidase inhibitors in reserpine-treated rats.
    Clarke DE
    Br J Pharmacol; 1970 Jan; 38(1):1-11. PubMed ID: 4391732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of caroxazone, a reversible monoamine oxidase inhibitor, on the pressor response to oral tyramine in man.
    Martini A; Bonollo L; Nicolis FB; Sega R; Palermo A
    Br J Clin Pharmacol; 1981 Jun; 11(6):611-5. PubMed ID: 7272178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interaction of tricyclic antidepressants with noradrenaline and 5-hydroxytryptamine in peripheral preparations of the rat].
    Van Dorsser W; Dresse A
    Arch Int Pharmacodyn Ther; 1976 Mar; 220(1):164-76. PubMed ID: 952575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology of tomoxetine, a potential antidepressant.
    Zerbe RL; Rowe H; Enas GG; Wong D; Farid N; Lemberger L
    J Pharmacol Exp Ther; 1985 Jan; 232(1):139-43. PubMed ID: 3965689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral tyramine pressor test and the safety of monoamine oxidase inhibitor drugs: comparison of brofaromine and tranylcypromine in healthy subjects.
    Bieck PR; Antonin KH
    J Clin Psychopharmacol; 1988 Aug; 8(4):237-45. PubMed ID: 3209716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug induction of hepatic enzymes in the elderly.
    Pearson MW; Roberts CJ
    Age Ageing; 1984 Sep; 13(5):313-6. PubMed ID: 6496244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination and comparison of the pressor effect of tyramine during long-term moclobemide and tranylcypromine treatment in healthy volunteers.
    Berlin I; Zimmer R; Cournot A; Payan C; Pedarriosse AM; Puech AJ
    Clin Pharmacol Ther; 1989 Sep; 46(3):344-51. PubMed ID: 2673623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of caroxazone, a reversible monoamine oxidase inhibitor, on the pressor response to intravenous tyramine in man.
    Martini A; Bonollo L; Nicolis FB; Sega R; Palermo A; Braibanti E
    Br J Clin Pharmacol; 1981 Jun; 11(6):605-10. PubMed ID: 7272177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyramine pressor test: implications and limitations.
    Ghose K
    Methods Find Exp Clin Pharmacol; 1984 Aug; 6(8):455-64. PubMed ID: 6492942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of moclobemide, a new reversible monoamine oxidase inhibitor, on absorption and pressor effect of tyramine.
    Korn A; Da Prada M; Raffesberg W; Gasic S; Eichler HG
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):17-23. PubMed ID: 2450251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.